*** For immediate use May 17, 2012
Boulder, CO, USA and Tokyo, Japan - May XX, 2012
SomaLogic, Inc., and NEC Corporation (NEC; TSE: 6701) today
announced the release of SomaSuite, a professional software
tool developed by NEC that provides simple, reliable and
direct access to the highly multiplexed proteomic data
generated by SomaLogic's SOMAscan assay technology.
SomaSuite Version 1.0 enables all clinical researchers,
regardless of their level of bioinformatic expertise, to
analyze the hundreds of measurements over thousands of
proteins produced by the SOMAscan assay. SomaSuite provides
an intuitive graphic display that enables researchers to
quickly discover significant protein expression changes in
their biological samples.
Since their first agreement in 2010, SomaLogic and NEC have
worked to establish a long-term strategic relationship
between the companies to integrate NEC's information
technology as an enhancement of SomaLogic's products
for life sciences research, drug discovery and development,
and diagnostics. SomaSuite is the first product developed
under this agreement, and it is now included as a part of
the SOMAscan assay service.
SomaSuite is a stand-alone, Windows-based software tool
designed for simplicity and usability. It features a
workflow-driven interface that guides the user from raw
data to results, including:
-
Rapid grouping (and re-grouping) of samples for easy
user-generated comparisons;
-
Tests to identify difference in protein response (or
differential protein regulation) between groups of
samples;
-
Visualization of results in a variety of formats;
-
Selection of proteins of interest identified during the
analysis steps.
"Our strategic partnership with NEC is a critical
element of our own efforts to unlock protein biomarker
discovery for our many collaborators in biopharmaceuticals
and academia," said Larry Gold, Ph.D., CEO and Chairman
of the Board of SomaLogic. "The release of SomaSuite
draws on NEC's expertise in developing software that
creates value from complex datasets, and makes our SOMAscan
technology accessible to everyone interested in protein
biomarker discovery."
"We undertook this collaboration with SomaLogic to
leverage the unique strengths of both companies for the
purpose of optimizing the use of protein biomarkers to
provide better healthcare, and thus to enhance people's
lives worldwide," said Takuya Yamaguchi, General Manager
of NEC's Medical Solutions Division. "Providing
quick and direct access to results from the powerful protein
biomarker platform is an important step towards realizing
that shared goal."
***
About SomaLogic
SomaLogic, Inc., is a privately held biomarker discovery
and clinical diagnostics company based in Boulder,
Colorado. The company's mission is to use its
proprietary proteomic technology to develop enhanced
protein analysis tools and reagents for the life sciences
community, to facilitate biomarker discovery and validation
for diagnostic and therapeutic applications, and to develop
and commercialize clinical diagnostic products that will
improve the delivery of healthcare by offering timely and
accurate diagnostic information to physicians and their
patients. Further information about SomaLogic can be found
at www.somalogic.com.
About NEC Corporation
NEC Corporation is a leader in the integration of IT and
network technologies that benefit businesses and people
around the world. By providing a combination of products
and solutions that cross utilize the company's
experience and global resources, NEC's advanced
technologies meet the complex and ever-changing needs of
its customers. NEC brings more than 100 years of expertise
in technological innovation to empower people, businesses
and society. For more information, visit NEC at
http://www.nec.com.
About SOMAscan(TM)/SOMAmers(TM)
SomaLogic's proprietary SOMAscan(TM) proteomic
technology platform underlies a rapidly growing number of
new diagnostic and therapeutic opportunities. The power of
the SOMAscan platform comes from its use of a new
generation of nucleic acid-based protein-binding reagents,
called SOMAmers(TM) (Slow Off-rate Modified Aptamers). The
unique physical properties of SOMAmers empower the accurate
detection and measurement of thousands of proteins over a
wide range of concentrations in just a few drops of blood
(or other tissues), all in a single SOMAscan assay.
Recommend:
